Skip to main content
. 2021 May 17;12(7):1121–1141. doi: 10.1039/d1md00045d

Fig. 6. Biologically active molecules like dexmedetomidine (5), TLSC702 (6), LY294002 (7), indoprofen (8), nalidixic acid (9), rapamycin (10), and polydatin (11) showing PKM2 inhibitory properties. The red portion in the molecule signifies the part with PAINS propensity.

Fig. 6